Roble, Belko & Company, Inc Hims & Hers Health, Inc. Transaction History
Roble, Belko & Company, Inc
- $687 Million
- Q2 2025
A detailed history of Roble, Belko & Company, Inc transactions in Hims & Hers Health, Inc. stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 40 shares of HIMS stock, worth $2,077. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40Holding current value
$2,077% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HIMS
# of Institutions
561Shares Held
160MCall Options Held
14.1MPut Options Held
18.9M-
Vanguard Group Inc Valley Forge, PA18.5MShares$960 Million0.01% of portfolio
-
Black Rock Inc. New York, NY14.6MShares$757 Million0.01% of portfolio
-
New View Hms Spv Partners, LLC Burlingame, CA9.66MShares$502 Million100.0% of portfolio
-
Goldman Sachs Group Inc New York, NY8.16MShares$424 Million0.04% of portfolio
-
Farallon Capital Management LLC San Francisco, CA7.95MShares$413 Million1.35% of portfolio
About Hims & Hers Health, Inc.
- Ticker HIMS
- Exchange NYSE
- Sector Consumer Defensive
- Industry Household & Personal Products
- Shares Outstandng 198,759,008
- Market Cap $10.3B
- Description
- Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurri...